" class="no-js "lang="en-US"> Banook Group - Medtech Alert
Sunday, October 26, 2025
Banook Group | Pharmtech Focus

Banook Group

About Banook Group

Banook Group

Banook Group is one of the few established international providers capable of supplying cardiac safety, central imaging and endpoint adjudication services to pharmaceutical, medical device and biotech companies, CROs and nonprofit organizations.
Its mission is to help its clients invent tomorrow’s healthcare, using qualitative, reliable and innovative solutions in early to late stage clinical trials and ultimately to bring new solutions to the market for the benefit of patients worldwide.
Its medical and regulatory expertise, quality-driven approach and team availability make the Banook Group a key player for clinical trial services.
Founded in 1999, Banook Group is a non-listed family company. Financially stable and strong, the group operates on an international scale, maintaining offices at its headquarters in Nancy (France) and in the United States (Mystic, CT).
To learn more about the Banook Group and its subsidiaries (formerly CardiaBase, Banook Central Imaging and Banook Inc.), please visit our new website www.banookgroup.com

Related Story

Banook Group Acquires German Counterpart Nabios GmbH to Become a European Leader in Cardiac Safety Services

September 23 2021

The Banook Group, specialized in cardiac safety, clinical imaging and endpoint adjudication, today announces the […]